The article describes negative effects of inflammation which persists long after the underlying condition has been addressed, due to persistently elevated levels of the HMGB1 protein. It notes that "anti-HMGB1 treatment given several days after a serious illness can reduce cognitive decline in mice" and proposing that these results might some day be replicated in humans.